Drug Shortage Report for MODULON
| Report ID | 3020 |
| Drug Identification Number | 00803499 |
| Brand name | MODULON |
| Common or Proper name | TRIMEBUTINE MALEATE |
| Company Name | APTALIS PHARMA CANADA ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | TRIMEBUTINE MALEATE |
| Strength(s) | 200MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | A03AA |
| ATC description | DRUGS FOR FUNCTIONAL BOWEL DISORDERS |
| Reason for shortage | Shortage of an inactive ingredient or component. |
| Anticipated start date | 2017-05-05 |
| Actual start date | 2017-05-10 |
| Estimated end date | 2017-07-14 |
| Actual end date | 2017-07-14 |
| Shortage status | Resolved |
| Updated date | 2017-07-15 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v18 | 2017-07-15 | English | Compare |
| v17 | 2017-07-14 | French | Compare |
| v16 | 2017-07-14 | English | Compare |
| v15 | 2017-07-05 | French | Compare |
| v14 | 2017-07-05 | English | Compare |
| v13 | 2017-05-11 | English | Compare |
| v12 | 2017-05-10 | French | Compare |
| v11 | 2017-05-10 | English | Compare |
| v10 | 2017-05-06 | English | Compare |
| v9 | 2017-04-28 | French | Compare |
| v8 | 2017-04-28 | English | Compare |
| v7 | 2017-04-21 | French | Compare |
| v6 | 2017-04-21 | English | Compare |
| v5 | 2017-04-17 | French | Compare |
| v4 | 2017-04-17 | English | Compare |
| v3 | 2017-04-11 | English | Compare |
| v2 | 2017-03-16 | French | Compare |
| v1 | 2017-03-16 | English | Compare |
Showing 1 to 18 of 18